Rates of Positive Basal Cell Carcinomas (BCCs) in Re-excisions

Rambam Health Care Campus

Status: Completed

Conditions: Basal Cell Carcinoma

Study type: Observational

Funder types: Other

Identifiers

NCT01403480

0064-11-RMB-CTIL

Details and patient eligibility

About

Basal Cell Carcinoma (BCC) is the most common malignant growth in the world. Treatment is primarily surgical with the goal of excising the growth in its entirety. When pathology results show that this has not been achieved, a re-excision is routinely performed. This study examines retrospectively the percentage of re-excisions of BCC that actually proved to be positive (exhibited growth) among those re-excisions performed at Rambam Healthcare Campus and Zvulun Community Medical Center during the years 2008-10.

Enrollment: 600 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

All patients that underwent an incomplete BCC excision during the years 2008-2010.

Exclusion criteria

Patients that underwent an incomplete BCC excision and were subsequently referred to undergo a MOHS procedure.